Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by askretka


V.SMN

RE:Eric Coffin - Sun Summit is still a BUY in this range.

I agree. Next drill program should firm up the price and potential of the...

February 4, 2022

V.ISGI

New investor Presentation on their Website

Very good presentation. Lists all their partners and the Multi billions of...

February 4, 2022

T.ONC

CAR-T cells cures cancer!! CONFIRMED!!!

Headline in Endpoints a pharma newsletter. Carl June: We can now conclude...

February 3, 2022

T.GEO

RE:Massive 54 million $ win

Nice contract! Bought my position at $1.80 to 1.90 last year and am holding...

February 1, 2022

T.ONC

Another hint that Breast Cancer data may be better than expe

Initially Adlai Nortye was planning to stay away from breast cancer. From...

January 29, 2022

T.ONC

China biotech Supersonic. Aldai Nortye even Faster

https://pharmaboardroom.com/interviews/carsten-lu-ceo-adlai-nortye-china/ ---...

January 29, 2022

T.ONC

RE:Adlai Nortye

Yes that's interesting. I thought initial plan was to do study in...

January 29, 2022

T.ONC

RE:RE:RE:Adlai Nortye

Good link interesting. China is way behind USA in using immunotherapy as well...

January 27, 2022

V.ISGI

Nice 31% jump and a new deal

Wasn't expecting that yet but they are positioned for a nice runup in a...

January 27, 2022

T.ONC

Advantage Oncolytics Biotech!!!

- 15 Dec 2021--- Treatment with intravenous pelareorep plus azacitidine...

January 27, 2022

T.ONC

RE:Bispecific T-cell engagers + ONCY pelareorep (reovirus)

Ya BITES and Virus therapy looks really interesting. The virus infection also...

January 23, 2022

V.RGD

Resource estimate by Q2 2022

"The phase 4, 15,000-meter drill program, is expected to be completed by...

January 20, 2022

T.ONC

Oncolytics mentioned in Solid Tumor CAR-T article

https://www.fiercebiotech.com/research/stop-sugarcoating-cancer-cells-to...

January 20, 2022

T.ONC

For Notable

Not sure how I missed this one before but you may have seen it or posted it...

January 19, 2022

T.ONC

RE:RE:ONCY - Benzinga.com - New Presentation

Thanks for that post. Hadn't seen that. Matt does a very good job...

January 17, 2022

T.ONC

42$ CDN Buyout target

I'm sticking my neck way out there and feel free to bash me or accuse me...

January 15, 2022

T.ONC

CAR-T Potential from newsletter

Pelareorep and CAR T Cell Therapy in Solid Tumors: Potentially Opening aNew...

January 13, 2022

T.ONC

Biomarkers and Personalized Medicine 721 Billion

" Personalized medicine is mainly used in clinical decision making by...

January 9, 2022

V.ISGI

Could be one of the big winners of 2022

Once Omicron is under control the pent up demand for travel is incredible...

January 8, 2022

T.ONC

Immunotherapies only 13% effect on their own

FAST FACT Despite the high price tag and rising promise of immunotherapy, the...

January 8, 2022

Featured Company